文献速递颈动脉与弓上血管

有症状患者经股动脉颈动脉支架置入术后再干预率更高:一项卒中中心2015-2024年回顾性队列研究

Higher Rate of Reinterventions after Transfemoral Carotid Artery Stenting in Symptomatic Patients: A Retrospective Stroke Center's Cohort Study Between 2015-2024.
PubMed 文献 · Ann Vasc Surg · 2025-01-22

该单中心回顾性队列研究分析了2015至2024年间183次颈动脉血运重建(TF-CAS 118例、CEA 55例、TCAR 10例),发现有症状患者中TF-CAS术后再狭窄率和再干预率均高于CEA,但30天和中期复合终点相似。

要点

  • TF-CAS组再狭窄率11.0%、再干预率12.7%,均高于CEA组(P=0.01和P<0.01)。
  • CEA组30天同侧卒中、心梗和死亡合计0.0%,TF-CAS组5.0%(P=0.18)。
  • 中期同侧TIA、卒中、心梗和死亡合计CEA组21.8% vs TF-CAS组22.9%(P=0.88)。

核心结论

  • TF-CAS与较高的围手术期死亡率相关但无统计学显著性,尤其在70岁以上患者中。
  • CEA组与TF-CAS组30天和中期包括同侧卒中、心梗和死亡的复合终点相似。
  • TF-CAS组再狭窄更常见,导致再干预率更高,最早再干预发生在初次干预后2个月。
  • 作者认为仔细的患者选择可能减少接受TF-CAS患者再干预的需求。

研究设计与样本

  • 单机构回顾性队列研究,2015年至2024年开展。
  • 纳入干预前6个月内因同侧颈动脉狭窄出现局灶性神经系统症状的所有患者。
  • 共分析178例患者的183次干预(TF-CAS 118次、CEA 55次、TCAR 10次),平均年龄71.5±9.6岁。
  • 主要结局为30天内卒中、心肌梗死和死亡;次要结局包括中期卒中、心梗、死亡、再狭窄和再干预。
  • 统计分析使用R v4.4.1,亚组分析采用Kaplan-Meier曲线。

主要发现

  • TCAR患者外周动脉疾病患病率30.0%,高于CEA的5.5%和TF-CAS的5.3%(P=0.04)。
  • TF-CAS患者术前卒中率68.6%,高于CEA的50.9%(P=0.02);卒中严重程度无差异(NIHSS TF-CAS 6.8±7.2 vs CEA 5.7±7.1,P=0.86)。
  • CEA患者TIA率43.6%,高于TF-CAS的25.0%(P=0.02);ABCD2评分无差异(CEA 3.6±1.6 vs TF-CAS 3.4±1.5,P=0.92)。
  • CTA测得颈动脉狭窄程度TF-CAS组75.1±17.2,高于CEA组69.6±18.3(P=0.01)。
  • CEA组住院中位数9.0天(IQR 2.0-15.0),短于TF-CAS组的14.0天(IQR 2.0-16.0)(P<0.01)。

关键数值与推荐

  • 30天同侧卒中、心梗和死亡合计:CEA组0.0% vs TF-CAS组5.0%(P=0.18)。
  • 中期同侧TIA、卒中、心梗和死亡合计:CEA组21.8% vs TF-CAS组22.9%(P=0.88)。
  • 再狭窄率:TF-CAS组11.0%,高于CEA组(P=0.01)。
  • 再干预率:TF-CAS组12.7%,高于CEA组(P<0.01)。
  • CEA组短暂性脑神经损伤发生率5.5%,TF-CAS组为0.0%(P=0.03)。

临床怎么用

  • 作者认为仔细的患者选择可能减少接受TF-CAS患者再干预的需求。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Carotid artery stenosis is a significant contributor to ischemic strokes, and its surgical management includes carotid artery endarterectomy (CEA), transfemoral carotid artery stenting (TF-CAS), and transcarotid artery revascularization (TCAR). CEA has traditionally been preferred, but TF-CAS and TCAR are also excellent alternative options if the anatomy of the vessels allows them. This study reports our short- and mid-term outcomes after carotid artery revascularization in symptomatic patients at a stroke center. METHODS: This single-institution retrospective cohort study was conducted from 2015 to 2024. All patients with focal neurological symptoms attributable to ipsilateral carotid artery stenosis within 6 months before the intervention were included. Primary outcomes were stroke, myocardial infarction (MI), and death within 30 days. Secondary outcomes included mid-term stroke, MI, death, restenosis, and reinterventions. Statistical analyses were performed using R v 4.4.1, and Kaplan-Meier curves were used for sub-group analysis. RESULTS: A total of 183 interventions on 178 patients were analyzed (TF-CAS = 118, CEA = 55, and TCAR = 10), with a mean age of 71.5 ± 9.6 years. The cohort included 123 male (69.1%) and 55 female (30.9%) patients. Peripheral artery disease (PAD) prevalence was higher in TCAR patients (30.0%) compared to CEA (5.5%) and TF-CAS (5.3%) (P = 0.04). TF-CAS patients had a higher rate of preoperative stroke (68.6%) compared to CEA (50.9%) (P = 0.02); though there was no difference in stroke severity (NIHSS in TF-CAS: 6.8 ± 7.2 vs. CEA: 5.7 ± 7.1; P = 0.86). CEA patients had a higher rate of TIAs (43.6%) than TF-CAS (25.0%) (P = 0.02); but their ABCD2 score did not differ (CEA 3.6 ± 1.6 vs. TF-CAS 3.4 ± 1.5, P = 0.92). Preoperative amaurosis fugax rates were similar (TF-CAS:16.4% vs. CEA 14.4% P = 0.72) among groups. Carotid artery degree of stenosis measured by computed tomography angiography (CTA) was significantly higher in TF-CAS (75.1 ± 17.2) than in CEA (69.6 ± 18.3) (P = 0.01). A vulnerable plaque was found in 60% of CEA and 50% of TF-CAS patients (P = 0.42). TF-CAS had longer hospitalizations than CEA patients (TF-CAS median of 14.0 (IQR: 2.0-16.0) days versus CEA median of 9.0 (IQR 2.0-15.0) days; P < 0.01). Transient cranial nerve injuries occurred in 5.5% of CEA patients but none in TF-CAS patients (P = 0.03). Thirty-day combined ipsilateral stroke, MI and death were 0.0% for CEA and 5.0% for TF-CAS (P = 0.18). Two perioperative deaths occurred among TF-CAS patients, who were older than 70 years of age and with NIHSS of 19 and 8 on presentation. Mid-term follow-up was 1.2 ± 1.4 years. Mid-term combined ipsilateral TIA, stroke, MI, and death were 21.8% for CEA and 22.9% for TF-CAS (P = 0.88). TF-CAS had a higher rate of restenosis (11.0%, P = 0.01) and reintervention (12.7%, P < 0.01) compared to CEA. Reinterventions included cutting-balloon angioplasties, CEA, and TCAR. CONCLUSION: TF-CAS is associated with higher, but no significant perioperative mortality, particularly in patients over 70 years of age. Thirty-day and mid-term composite outcomes including ipsilateral stroke, MI, and death are similar in the CEA and TF-CAS groups. However, restenosis occurred more frequently in the TF-CAS group, leading to a higher rate of reintervention, the earliest occurring 2 months after initial intervention. Careful patient selection may mitigate the need for reinterventions in patients undergoing TF-CAS.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Esquetini-Vernon C, Meschia JF, Huang J, et al. Higher Rate of Reinterventions after Transfemoral Carotid Artery Stenting in Symptomatic Patients: A Retrospective Stroke Center's Cohort Study Between 2015-2024. Ann Vasc Surg. 2025. PMID: 39855389. doi:10.1016/j.avsg.2024.12.074

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。